News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
The protein engineering company has named Ross Taylor as senior vice president and chief financial officer (CFO), following the retirement of Gordon Sangster.
Taylor was the CFO of Abaxis from 2015 until the company was sold to Zoetis in July 2018.
“I am thrilled to join Codexis at this exciting time as the company pursues growth across its core business and an increasing number of verticals,” Taylor told us. “With its CodeEvolver technology Codexis has attractive opportunities in multiple industrial segments, including pharmaceutical manufacturing, food and beverage, molecular diagnostics, and others.”
“Furthermore, CodeEvolver is fueling the company’s novel biotherapeutic discovery pipeline further demonstrating the value of the technology and significantly enhancing the company’s potential. I look forward to working with John, the entire management team and the board to drive the company’s future success and enhance value for our investors.”